Tejnaksh Healthcare Ltd.
| BSE: 539428 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE030T01019 |
| BSE 09:07 | 24 May | 157.00 |
17.10 (12.22%) |
OPEN
157.00 |
HIGH
157.00 |
LOW
157.00 |
| NSE 05:30 | 01 Jan | Tejnaksh Healthcare Ltd |
| OPEN | 157.00 |
| PREVIOUS CLOSE | 139.90 |
| VOLUME | 1 |
| 52-Week high | 194.00 |
| 52-Week low | 56.00 |
| P/E | 63.31 |
| Mkt Cap.(Rs cr) | 160 |
| Buy Price | 142.50 |
| Buy Qty | 33.00 |
| Sell Price | 157.00 |
| Sell Qty | 99.00 |
Tejnaksh Healthcare Ltd. (TEJNAKSHHEALTH) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 559.95 | 2.10 | 0.38 | 15823.68 |
| Cipla | 975.00 | -3.60 | -0.37 | 13900.58 |
| Dr Reddy's Labs | 4252.25 | 5.95 | 0.14 | 13349.10 |
| Sun Pharma.Inds. | 922.10 | 6.60 | 0.72 | 12803.21 |
| Lupin | 623.75 | -14.65 | -2.29 | 11055.93 |
| Apollo Hospitals | 3766.70 | 99.05 | 2.70 | 9153.00 |
| Zydus Lifesci. | 365.00 | 7.85 | 2.20 | 7790.40 |
| Glenmark Pharma. | 404.00 | -3.40 | -0.83 | 7567.93 |
| Divi's Lab. | 3910.00 | -396.60 | -9.21 | 6798.61 |
| Ipca Labs. | 972.00 | -17.00 | -1.72 | 5114.11 |
| Laurus Labs | 567.00 | -7.45 | -1.30 | 4768.72 |
| Gland Pharma | 2942.15 | -128.05 | -4.17 | 3462.88 |
| Glaxosmi. Pharma | 1555.00 | 11.40 | 0.74 | 3193.74 |
| Granules India | 281.00 | 9.80 | 3.61 | 3134.98 |
| Jubilant Pharmo | 419.95 | 11.95 | 2.93 | 2709.50 |
| Biocon | 342.55 | 2.90 | 0.85 | 2028.40 |
| IOL Chemicals | 385.50 | -10.75 | -2.71 | 1966.98 |
| Aarti Drugs | 428.00 | 8.00 | 1.90 | 1914.89 |
| Glenmark Life | 448.95 | 1.55 | 0.35 | 1885.17 |
| Strides Pharma | 305.45 | -2.15 | -0.70 | 1857.57 |
Quick Links for Tejnaksh Healthcare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
